Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001179110-13-016608)

Filing Details

Accession Number:: 0001179110-13-016608
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-11-15 17:58:26
Reporting Period:: 2013-11-13

Filing Date:: 2013-11-15
Accepted Time:: 2013-11-15 17:58:26
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1157601	Synta Pharmaceuticals Corp	SNTA	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1325712	R Keith Gollust	C/O Synta Pharmaceuticals Corp. 45 Hartwell Avenue Lexington MA 02421		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-11-13	150,000	$3.75	2,823,383	No	4	P	Indirect	By Wyandanch Partners, L.P.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By Wyandanch Partners, L.P.

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	332,255	Direct
Common Stock	175,000	Indirect	By Keith R. Gollust Roth IRA

Footnotes

The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, if any, and the inclusion of these shares in this report shall not be deemed an admission of the beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.